FDA Inspection 993732 — WakeMed IRB
The FDA completed an inspection of WakeMed IRB on Dec 8, 2016 in Raleigh, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 8, 2016
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Raleigh, NC (United States)
Additional Details
IRB